JP2011520893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520893A5 JP2011520893A5 JP2011509591A JP2011509591A JP2011520893A5 JP 2011520893 A5 JP2011520893 A5 JP 2011520893A5 JP 2011509591 A JP2011509591 A JP 2011509591A JP 2011509591 A JP2011509591 A JP 2011509591A JP 2011520893 A5 JP2011520893 A5 JP 2011520893A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- compound according
- arylalkyl
- therapeutic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 230000001225 therapeutic Effects 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- -1 hydrate Substances 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000009745 Eye Disease Diseases 0.000 claims 1
- 208000004296 Neuralgia Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 208000009935 Visceral Pain Diseases 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229920000728 polyester Polymers 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrugs Drugs 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Claims (12)
- 夫々のR1 が独立にアルキル、フルオロ、クロロ、ブロモ、トリフルオロメチル、ヒドロキシ、又はメトキシである、請求項1記載の化合物。
- 夫々のR1 がクロロである、請求項1記載の化合物。
- R2 がアルキル又はアリールアルキルである、請求項1記載の化合物。
- R2 がC1 -C6 アルキルである、請求項4記載の化合物。
- R2 がアリールアルキルである、請求項1記載の化合物。
- nが1又は2である、請求項1記載の化合物。
- 請求項1〜8のいずれか一項に記載の化合物を含む、眼の疾患の治療用組成物。
- 請求項1〜8のいずれか一項に記載の化合物を含む、慢性の痛みを治療するための治療用組成物。
- 請求項1〜8のいずれか一項に記載の化合物を含む、神経痛を治療するための治療用組成物。
- 請求項1〜8のいずれか一項に記載の化合物を含む、内臓痛を治療するための治療用組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5399708P | 2008-05-16 | 2008-05-16 | |
US61/053,997 | 2008-05-16 | ||
PCT/US2009/043478 WO2009140204A2 (en) | 2008-05-16 | 2009-05-11 | Selective subtype alpha 2 adrenergic agents and methods for use thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011520893A JP2011520893A (ja) | 2011-07-21 |
JP2011520893A5 true JP2011520893A5 (ja) | 2012-07-05 |
JP5710470B2 JP5710470B2 (ja) | 2015-04-30 |
Family
ID=40910877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011509591A Expired - Fee Related JP5710470B2 (ja) | 2008-05-16 | 2009-05-11 | 選択的サブタイプアルファ2アドレナリン作用薬及びこれらの使用方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8486985B2 (ja) |
EP (2) | EP2285372A2 (ja) |
JP (1) | JP5710470B2 (ja) |
AU (1) | AU2009246572A1 (ja) |
CA (1) | CA2724435A1 (ja) |
WO (1) | WO2009140204A2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2603215A4 (en) * | 2010-08-11 | 2015-08-05 | Philadelphia Health & Educatio | NEW DOPAMINERGIC D3 RECEPTOR AGONISTS FOR TREATING DYSKINESIA IN PARKINSON'S DISEASE |
AU2014342520B2 (en) | 2013-10-28 | 2019-08-08 | Drexel University | Novel treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6708160A (ja) | 1966-06-30 | 1968-01-02 | ||
US5212176A (en) | 1990-06-29 | 1993-05-18 | Abbott Laboratories | R(+)-terazosin |
DE60021521T4 (de) | 1999-09-29 | 2006-09-21 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipecotamide zur behandlung von integrin vermittelten störungen |
-
2009
- 2009-05-11 WO PCT/US2009/043478 patent/WO2009140204A2/en active Application Filing
- 2009-05-11 EP EP09747288A patent/EP2285372A2/en not_active Withdrawn
- 2009-05-11 EP EP11155339A patent/EP2319511A3/en not_active Withdrawn
- 2009-05-11 AU AU2009246572A patent/AU2009246572A1/en not_active Abandoned
- 2009-05-11 JP JP2011509591A patent/JP5710470B2/ja not_active Expired - Fee Related
- 2009-05-11 US US12/992,535 patent/US8486985B2/en active Active
- 2009-05-11 CA CA2724435A patent/CA2724435A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2500681C2 (ru) | Замещенные гетероциклом пиперазинодигидротиенопиримидины | |
HRP20171696T1 (hr) | 3,4-dihidroizokinolin-2(1h)-ilni spojevi | |
HK1225970A1 (zh) | 利用拉喹莫德治療亨廷頓氏病 | |
JP2013522326A5 (ja) | ||
JP2014516033A5 (ja) | ||
RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
JP2008513516A5 (ja) | ||
RU2017121588A (ru) | Конденсированные бициклические соединения для лечения заболевания | |
JP2013508279A5 (ja) | ||
RU2015143610A (ru) | Лечение катаплексии | |
JP2009542595A5 (ja) | ||
JP2013510120A5 (ja) | ||
EA201691939A1 (ru) | Способ лечения рака с использованием 3-(5-амино-2-метил-4-оксо-4h-хиназолин-3-ил)пиперидин-2,6-диона | |
JP2013523733A5 (ja) | ||
JP2014500861A5 (ja) | ||
JP2009501745A5 (ja) | ||
JP2013515752A5 (ja) | ||
JP2012530758A5 (ja) | ||
JP2010522710A5 (ja) | ||
JP2013502441A5 (ja) | ||
MX2014003801A (es) | Derivados de pirimidin-4-ona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral. | |
JP2016537338A5 (ja) | ||
JP2017537937A5 (ja) | ||
JP2013522368A5 (ja) | ||
JP2015516419A5 (ja) |